nference (a company dedicated to transforming healthcare by making biomedical data computable) announced a multi-year licensing agreement with the Bill & Melinda Gates Foundation. This collaboration provides the Gates Foundation access to nference’s nSights platform, where researchers can access a repository of extensive clinical data and expertise from top-ranked medical institutions.
nSights’ platform – utilizing nference’s federated network – will provide resources to help the Gates Foundation more easily visualize and investigate pressing issues affecting world health today. and Tthe platform offers data-driven insights to help research teams learn more about healthcare, diseases, and treatments relevant to the Foundation’s interests. This knowledge will contribute to informed decision-making and the development of impactful treatments.
nference’ extensive de-identified, longitudinal data includes decades of clinical notes along with rich patient histories, vitals, lab tests, radiology images, digital pathology, genomics, and electrophysiology waveforms. And the company’s federated data platform, comprised of premier healthcare organizations, including Mayo Clinic, Duke Health, Banner Health, Vanderbilt University Medical Center, and Emory Healthcare, enables advanced research and custom AI model development.
Through unprecedented access to data from over 40 million patient journeys, the company’s partners can accelerate target discovery, optimize clinical trial design, and enhance lifecycle management.
KEY QUOTE:
“At the heart of this collaboration lies our commitment to supporting humanitarian causes with our cutting-edge technology platform, driving near-term tangible impact in health equity. Through access to nference’s federated AI – with its depth of multimodal and unprecedented longitudinal data – we aim to accelerate the contribution of modern and innovative healthcare solutions on a global scale.”
- Maulik Nanavaty, President of Ventures at nference & CEO at Anumana
